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Objective: Toevaluateamniotic fluid glucose,matrix metalloproteinase (MMP)-9, interleukin (IL)-6, andIL-12for
diagnosing subclinical chorioamnionitis in women with preterm labor.
Methods: Forty-four women in preterm labor at 22–35 weeks gestation with suspected subclinical
chorioamnionitisunderwentamniocentesis.AmnioticfluidanalysisincludedGramstain,culture,anddetermination
of glucose, MMP-9, IL-6, and IL-12 concentrations. Median values of these analytes were compared using the
Mann-Whitney U test. Sensitivity, specificity, and positive and negative predictive values were calculated for tests
using a positive amniotic fluid culture or delivery within 24 hours as the key outcome variables.
Results: Amniotic fluid concentrations of glucose, MMP-9, and IL-6 correlated closely with positive culture or
delivery within 24 hours. IL-12 concentrations did not correlate with either a positive culture or delivery within
24 hours.
Conclusions: Amniotic fluid glucose, MMP-9, and IL-6 reliably predict microbial invasion of the amniotic cavity or
imminent delivery. IL-12 values did not correlate with amniotic fluid culture results or imminent delivery.
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Intrauterine infection is an important cause of
spontaneous preterm birth1,2. Chorioamnionitis is
generallydiagnosedbasedonclinicalcriteria; how-
ever, even subclinical chorioamnionitis can result
in preterm labor. Microbial invasion of the
amniotic cavity increases maternal and neonatal
complications. For instance, women with sub-
clinical chorioamnionitis are more likely to
develop clinical chorioamnionitis, rupture of
membranes, and failure of tocolysis3-6. Neonates
born to mothers with subclinical chorioamnionitis
have increased rates of infection and other
morbidities5,7. Therefore, accurate identification
of the woman in preterm labor with subclinical
chorioamnionitis is important.
Microbiologic culture of amniotic fluid (AF)
obtained by transabdominal amniocentesis has
been the gold standard for diagnosing microbial
invasion of the amniotic cavity. The primary
disadvantages of this technique are delay in
reporting of test results and low sensitivity. From
the time amniocentesis has been performed, 2 to 3
days may elapse before a positive or negative
culture result is obtained. Sensitivity is diminished
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Clinical study 209by suboptimal culture techniques and by exacting
laboratory requirements needed to culture certain
organisms, such as anaerobes or mycoplasma
species. Additionally, infection of the decidua or
membranes may exist in the absence of cultivable
organisms in the AF. Hitti and colleagues8 showed
that a broad-spectrum bacterial 16S rRNA
polymerase chain reaction (PCR) assay was more
sensitive than culture for detecting organisms in
AF. Although PCR results can be obtained more
quickly than culture, this technology is not readily
available for clinical use and is subject to
contamination. Although PCR is more sensitive
than culture, this technique also fails to detect
organisms located solely in the fetal membranes or
decidua.
Other tests that have been used to diagnose
intrauterine infection include AF white blood cell
count, Gram stain, glucose concentration, and
interleukin (IL)-6 concentration. The most
accurate predictor of positive AF culture among
these tests is an elevated IL-6 concentration9.
However, this test has a low positive predictive
value (perhaps due to the limited sensitivity of
culture), is relatively expensive, and is not readily
available in most hospitals. Amniotic fluid glucose
analysis may be slightly less sensitive than IL-6, but
it is less expensive, can be obtained rapidly, and is
widely available.
A less well-established marker of subclinical
chorioamnionitis is matrix metalloproteinase
(MMP)-9. This substance is one of the gelatinases,
enzymes involved in the degradation of collagen,
basement membrane components, and proteo-
glycans10,11. In an investigation utilizing the same
cohort that we report on here, MMP-9 proved to
reliably predict positive AF culture or imminent
delivery12. However, like IL-6, MMP-9 is rela-
tively expensive and is not readily available for
clinical use.
IL-12 is a cytokine that, to our knowledge, has
not been evaluated in AF as a potential marker of
subclinical chorioamnionitis. IL-12 is produced
by several cell types, including macrophages, in
responsetoinfectiousagentsandisacentralmedia-
tor of the cell-mediated immune response13–15.
We are unaware of any studies comparing the
predictive value of all of these markers for sub-
clinical chorioamnionitis.Therefore,theobjective
ofourinvestigation was to comparethesensitivity,
specificity, positive predictive value (PPV), and
negative predictive value (NPV) of AF glucose,
MMP-9, IL-6, and IL-12 for diagnosing bacterial
infection of the AF in women with preterm
labor, intact membranes, and signs suggestive of
subclinical chorioamnionitis.
SUBJECTS AND METHODS
Women who presented to the Labor and Delivery
Unit at Shands Hospital at the University of
Florida at 22–35 weeks gestation with preterm
labor and the clinical suspicion of subclinical
chorioamnionitis underwent amniocentesis. The
suspicion of subclinical chorioamnionitis was
based on the presence of one of the following:
low-grade maternal temperature elevation (less
than 38°C), isolated fetal tachycardia, or poor
response to tocolysis. Women were approached
for inclusion in this prospective cohort study if
they had documented cervical change, at least 4
contractionsperhour,and a cervix that was at least
2 centimeters dilated or 80% effaced. If these
women hadrupturedmembranes, cervical dilation
of more than 5 centimeters, or had taken
antibiotics within the preceding 7 days, they were
excluded from the study. The Health Center
Institutional Review Board approved the
investigation. Between July 1, 1996 and May 31,
1998, 44 women met the inclusion criteria and
consented in writing to participate in the study.
The procedure for handling AF samples has
been described in another study12. Briefly, after
collection by transabdominal amniocentesis, AF
was analyzed by Gram stain, culture for aerobes,
anaerobes, and mycoplasmas, and glucose concen-
tration.Theresultsofthesetestswereusedtomake
decisions regarding clinical treatment of patients.
An additional aliquot of AF was centrifuged, and
the supernatant stored at -80°C.
The stored AF samples were analyzed for
MMP-9 concentration using gelatin zymography
and a commercially available enzyme-linked
immunosorbent assay (ELISA) system12. We used
quantitative sandwich enzyme immunoassays
(R&D Systems, Minneapolis, MN) to measure
total IL-6 and IL-12 concentrations in the same
stored AF samples. Concentrations of IL-6 and
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curve constructed from knownstandards. Samples
were analyzed undiluted. When concentrations
were greater than the highest standard concen-
tration, samples were diluted 1 : 100 and 1 : 1000
for final analysis. All samples were analyzed in
duplicate.
All women received intravenous magnesium
sulfate as first-line tocolysis. If AF glucose, Gram
stain, or culture were positive, tocolysis was
discontinued. None of the other AF test results
were available for use in clinical decision making.
Finally, antimicrobial therapy was initiated only
for prophylaxis against early-onset neonatal sepsis
withgroupBstreptococcusortreatmentofclinical
chorioamnionitis.
For the analysis of demographic variables, we
used the Yates-corrected z test. The Mann-
Whitney U test was used to compare median
values of MMP-9, IL-6, and IL-12 between
subjects with and without positive AF cultures.
Sensitivity, specificity, PPV,and NPV were calcu-
lated for AF glucose concentration, Gram stain,
MMP-9, IL-6, and IL-12 using a positive AF
culture as the principal outcome variable. Ninety-
five percent confidence intervals (CI) were
calculated for each of these values. To account for
cases ofprobablesubclinicalchorioamnionitiswith
negativecultures,werecalculated theperformance
characteristics of each marker changing the key
outcome variable to positive culture, positive
Gram stain, or spontaneous preterm birth within
24 hours of amniocentesis. Neither the interval
from amniocentesis to hospital discharge nor the
duration of tocolysis were specifically evaluated.
RESULTS
The demographic characteristics of this cohort
have been reported12. In brief, of the 44 women in
thestudy,six [14%(95% CI 4, 24)]hadpositive AF
cultures. Compared to those with negative AF
cultures, women with positive AF cultures were
more likely to beless than 28 weeks gestational age
and to be African-American. There were no
significant differences between these two groups
in terms of age, parity, or cervical dilation at
presentation.
The median MMP-9 concentration in the AF
of women with positive AF cultures was
557 ng/ml (interquartile range 352–730 ng/ml),
as compared to 0 ng/ml (interquartile range
0–0 ng/ml) for those with negative cultures
(p = 0.003)12. Similarly, median IL-6 concentra-
tions in AF were significantly higher in women
with positive AF cultures (53.8 ng/ml, inter-
quartile range 8.9–129.7) than in those with nega-
tive AF cultures (0.77 ng/ml, interquartile range
0.26–2.29) (p = 0.02). However, median IL-12
concentrations in AF were similar in women
with positive (70.6 pg/ml, interquartile range
64.5–74.1) andnegative (64.5 pg/ml, interquartile
range 50.4–68.0) AF cultures (p = 0.66).
Using positiveAFcultureasthecriterionforthe
diagnosis of subclinical chorioamnionitis, per-
formance statistics for IL-6, MMP-9, and glucose
areshowninTable1.Theresultsaredichotomized
using the lower limit of the interquartile range for
IL-6 and MMP-9 as cut-off values. For AF
glucose, we used a threshold (15 mg/dl) that has
been established by others and is in clinical use at
our center. Values below this threshold were
considered positive.
Details of subjects with positive cultures,
glucose, IL-6, or MMP-9 are shown in Table 2.
Premature rupture of membranes, clinical chorio-
amnionitis, or delivery within 24 hours of amnio-
centesis occurred in every case with a positive
cultureexcept one.Thiswoman’sAFsamplegrew
Xanthomonas maltophilia, a ubiquitous organism
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Test Sensitivity Specificity PPV NPV
IL-6 (> 8.9 ng/ml)
MMP-9 (> 351 ng/ml)
Glucose (< 15 mg/dl)
83% (53, 100)
83% (53, 100)
83% (53, 100)
89% (80, 99)
92% (84, 100)
87% (75, 99)
56% (23, 88)
63% (29, 96)
56% (23, 88)
97% (92, 100)
97% (92, 100)
97% (92, 100)
AF, amniotic fluid; PPV, positive predictive value; NPV, negative predictive value
Table 1 Performance statistics (95% confidence intervals) for AF concentrations of IL-6, MMP-9, and glucose using
positive AF culture as the key outcome variableSubclinical chorioamnionitis Edwards et al.
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GA
(weeks) Culture
Glucose
(mg/dl)
IL-6
(ng/ml)
MMP-9
(ng/ml) Pregnancy outcome
25
22
33
24
22
31
34
34
34
26
29
Lactobacillus
Fusobacterium
Xanthomonas maltophilia
Streptococcus viridans
Ureaplasma urealyticum
Mycoplasma hominis
Negative
Negative
Negative
Negative
Negative
13
< 10
38
< 10
< 10
< 10
12
< 10
14
< 10
23
9.0
26.9
0.1
80.7
423.6
129.7
36.5
66.8
1.6
233.4
86.4
352
730
0
452
662
1066
340
933
0
860
0
PROM and Cesarean delivery within 48 h
Treated with antibiotics, PTL and SVD
11 days after amniocentesis
No treatment, SVD at 37 weeks
PTL and SVD in < 24 h
Labor induced due to clinical
chorioamnionitis, SVD in < 24 h
PTL and SVD in < 24 h
PTL and SVD in < 24 h
PTL and SVD in < 24 h
Labor induced after PROM at 36 weeks,
SVD 15 days after amniocentesis
Labor induced due to GNR on AF Gram
stain; SVD in < 24 h
PTL and SVD in < 24 h
AF, amniotic fluid; GA, gestational age; PROM, premature rupture of membranes; PTL, spontaneous preterm labor; SVD, spontaneous
vaginal delivery
Table 2 Characteristics of women with positive AF cultures, glucose, IL-6, or MMP-9
Test Sensitivity Specificity PPV NPV
IL-6 (> 8.9 ng/ml)
MMP-9 (> 351 ng/ml)
Glucose (< 15 mg/dl)
100% (94, 100)
78% (51, 100)
90% (71, 100)
100% (97, 100)
100% (97, 100)
87% (75, 99)
100% (94, 100)
100% (93, 100)
89% (69, 100)
100% (97, 100)
94% (86, 100)
97% (93, 100)
AF, Amniotic fluid; PPV, positive predictive value; NPV, negative predictive value
Table 3 Performance statistics (95% confidence intervals) for AF concentrations of IL-6, MMP-9, and glucose using
positive AF culture, positive AF Gram stain, or spontaneous preterm birth within 24 hours of amniocentesis as the key
outcome variables.
found on skin, in hospital water conduits, and in
deionized water16. This woman delivered at term,
four weeks after amniocentesis, without any
treatment. We judged this organism to be a
contaminant. Considering this case as having a
negative culture result and expanding the criteria
for diagnosis of probable subclinical chorio-
amnionitis to include positive AF culture, positive
AF Gram stain, or spontaneous preterm birth
within 24 hours of amniocentesis, we recalculated
the performance statistics for IL-6, MMP-9, and
glucose. These results are shown in Table 3.
DISCUSSION
The results of our study are in keeping with
the results of many others in that elevated AF
IL-6 concentrations correlated with positive
AF culture or imminent delivery17–19. The per-
formance statistics for IL-6 were not signifi-
cantly better than for AF glucose or MMP-9,
however our sample size was too small to detect
clinically important differences between methods.
Although IL-12 is produced by macrophages and
other cell types in response to microorganisms
and is thought to be key in bridging the innate
and cellular immune response13–15, we found
no relationship between AF IL-12 concentration
and either positive AF culture or imminent
delivery.
We observed that AF glucose, IL-6, and
MMP-9 correlated with one another and with
outcome. All three of these tests were positive in
seven cases. Each of these cases had either positiveculture results or delivered within 24 hours of
amniocentesis. Another woman with a negative
AF culture result who delivered within 24 hours
had a positive glucose and IL-6 and an MMP-9
concentration just below the threshold to be
considered positive.
Althoughinflammatory markers can be positive
in the absence of infection or the presence of a
remote site of infection, the most likely
explanation for cases with positive inflammatory
markers and negative AF culturesis the inability of
AF culture to detect all cases of intrauterine
infection. Possible explanations for negative AF
cultures when bacteria are present in the uterus
include: (1) the antibacterial properties of AF, (2)
the low sensitivity of culture, (3) the presence of
unculturable or difficult to culture organisms, and
(4) cases in which bacteria are located within the
membranes or between the membranes and
decidua. Clearly, by itself, AF culture is an
inadequate standard for detecting intrauterine
infection in the setting of preterm labor. Future
investigations that utilize PCR to identify
organisms in AF may reduce the discrepancy
between inflammatory markers and presence of
organisms in AF.
Because of issues related to cost and availability,
testsforIL-6andMMP-9concentrationsinAFare
notreadily available forclinical use. Ourdataindi-
cate that AF glucose determination is a reasonable
surrogate for these markers. Further investigation
is needed to justifymakingother markers clinically
available. Specifically, defining the temporal and
mechanistic roles of the various inflammatory
mediators in the pathophysiologyof preterm labor
is needed. However, the optimal clinical manage-
ment of a patient in preterm labor at a very early
gestational age with subclinical chorioamnionitis
has yet to be determined. If it could be shown that
tests for certain inflammatory markers become
positive before microorganisms can be detected in
AF and that the presence of these markers is reli-
ably linked to preterm delivery and/or neonatal
morbidity,thesetestswouldhavepracticalapplica-
tion to clinical practice. Finally, studies are needed
to answer the more fundamental question of why
some patients, butnotothers, develop intrauterine
infections that lead to preterm labor.
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